Sato Y, Murai M, Tsunoda J, Komatsu N, Muroi K, Yoshida M, Motoyoshi K, Sakamoto S, Miura Y
Department of Medicine, Jichi Medical School, Tochigi-ken, Japan.
Cancer Genet Cytogenet. 1991 Nov;57(1):53-8. doi: 10.1016/0165-4608(91)90189-2.
We describe herein a patient with acute promyelocytic leukemia (APL)-(ANLL-M3) whose bone marrow cells in the second relapse showed t(1;3)(p36;q21) together with t(15;17) (q22;q11-q12). Although a total of 21 patients with t(1;3) have been reported so far, among which three cases with de novo acute nonlymphocytic leukemia were included, our patient is the first case with APL. The hematologic findings in our case confirmed the previous observations that this anomaly is associated with relatively high platelet count and the multi-myeloid lineage involvement of leukemic cells. Our patient responded well to chemotherapy and achieved first and second remission with 42 months of total survival, contrary to our expectation that patients with this anomaly have a poor prognosis.
我们在此描述一名急性早幼粒细胞白血病(APL)-(急性非淋巴细胞白血病-M3型)患者,其第二次复发时骨髓细胞显示t(1;3)(p36;q21)以及t(15;17)(q22;q11-q12)。尽管迄今为止总共已报道了21例伴有t(1;3)的患者,其中包括3例原发性急性非淋巴细胞白血病,但我们的患者是首例APL病例。我们病例中的血液学表现证实了之前的观察结果,即这种异常与相对较高的血小板计数以及白血病细胞的多髓系谱系受累有关。我们的患者对化疗反应良好,实现了首次和第二次缓解,总生存期为42个月,这与我们预期的患有这种异常的患者预后不良相反。